183 related articles for article (PubMed ID: 15153801)
1. Histone-deacetylase inhibitors for the treatment of cancer.
Lindemann RK; Gabrielli B; Johnstone RW
Cell Cycle; 2004 Jun; 3(6):779-88. PubMed ID: 15153801
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer.
Martínez-Iglesias O; Ruiz-Llorente L; Sánchez-Martínez R; García L; Zambrano A; Aranda A
Clin Transl Oncol; 2008 Jul; 10(7):395-8. PubMed ID: 18628067
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds.
Blanquart C; François M; Charrier C; Bertrand P; Gregoire M
Curr Cancer Drug Targets; 2011 Oct; 11(8):919-28. PubMed ID: 21762083
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors: Potential in cancer therapy.
Marks PA; Xu WS
J Cell Biochem; 2009 Jul; 107(4):600-8. PubMed ID: 19459166
[TBL] [Abstract][Full Text] [Related]
5. Targeted histone deacetylase inhibition for cancer therapy.
Vigushin DM; Coombes RC
Curr Cancer Drug Targets; 2004 Mar; 4(2):205-18. PubMed ID: 15032670
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.
Frew AJ; Johnstone RW; Bolden JE
Cancer Lett; 2009 Aug; 280(2):125-33. PubMed ID: 19359091
[TBL] [Abstract][Full Text] [Related]
7. [Histone-deacetylases inhibitors: from TSA to SAHA].
Peixoto P; Lansiaux A
Bull Cancer; 2006 Jan; 93(1):27-36. PubMed ID: 16455503
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors: overview and perspectives.
Dokmanovic M; Clarke C; Marks PA
Mol Cancer Res; 2007 Oct; 5(10):981-9. PubMed ID: 17951399
[TBL] [Abstract][Full Text] [Related]
9. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
10. Prospects: histone deacetylase inhibitors.
Dokmanovic M; Marks PA
J Cell Biochem; 2005 Oct; 96(2):293-304. PubMed ID: 16088937
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors.
Marks PA; Richon VM; Miller T; Kelly WK
Adv Cancer Res; 2004; 91():137-68. PubMed ID: 15327890
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors in cancer treatment.
Vigushin DM; Coombes RC
Anticancer Drugs; 2002 Jan; 13(1):1-13. PubMed ID: 11914636
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.
Shankar S; Srivastava RK
Adv Exp Med Biol; 2008; 615():261-98. PubMed ID: 18437899
[TBL] [Abstract][Full Text] [Related]
14. HDAC inhibitors for the treatment of cancer.
Secrist JP; Zhou X; Richon VM
Curr Opin Investig Drugs; 2003 Dec; 4(12):1422-7. PubMed ID: 14763127
[TBL] [Abstract][Full Text] [Related]
15. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors: design, structure-activity relationships and therapeutic implications for cancer.
Marson CM
Anticancer Agents Med Chem; 2009 Jul; 9(6):661-92. PubMed ID: 19601748
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors selectively suppress expression of HDAC7.
Dokmanovic M; Perez G; Xu W; Ngo L; Clarke C; Parmigiani RB; Marks PA
Mol Cancer Ther; 2007 Sep; 6(9):2525-34. PubMed ID: 17876049
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors: molecular mechanisms of action.
Xu WS; Parmigiani RB; Marks PA
Oncogene; 2007 Aug; 26(37):5541-52. PubMed ID: 17694093
[TBL] [Abstract][Full Text] [Related]
20. The pharmaceutical potential of histone deacetylase inhibitors.
Elaut G; Rogiers V; Vanhaecke T
Curr Pharm Des; 2007; 13(25):2584-620. PubMed ID: 17897003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
